March 4th 2017
The L.O.M. Team comprising Scott Castanon, CEO of Symbient and designer of the L.O.M. retractable syringe, Doreen Guan of CE Medical China, FDA & CE certification consultants, Herbert Towning and Ralph Woloschuk, joined Ms. Shaw, the leader of the 3 man KDL engineers group, to begin the effort to produce L.O.M. syringes at the KDL Shanghai plant.
The molds were installed in the injection molding machines and produced perfect parts for the syringe assembly. The plans for developing the production line and training the KDL staff are being established with the intention to produce 3,000 syringes for testing and marketing.
The photo below is the L.O.M. team with KDL in their clean room where all of the mold parts mentioned above were produced.
As production and testing proceeds, shareholders will be kept fully informed.